- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01277861
Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment
Study Overview
Detailed Description
After obtaining approval from the institutional review board and informed consent, 100 patients, 18-64 years of age, scheduled for elective superficial and peripheral surgery of less than 2 h duration would be enrolled in this prospective, randomized, double-blind, placebo-controlled study. Patients will be randomly assigned to one of two anesthetic techniques according to a computer-generated random numbers table. Patients will receive either fentanyl or saline prior to induction of anesthesia, while the rest of the anesthetic and analgesic technique will be standardized for all patients.
Exclusion criteria will include obesity (body mass index >30), pregnancy, history of gastroesophageal reflux, hiatal hernia, significant cardiovascular, pulmonary (e.g., reactive airway disease), hepatic, renal, neurologic, metabolic, and endocrine disease as well as history of alcohol and drug abuse as well as those requiring tracheal intubation.
After premedication with midazolam 2 mg, patients will be transferred to the operating room. On arrival in the operating room standard monitors and the BIS (BiSpectral Index)monitor will be applied. Patients will then be preoxygenated for 2-3 minutes with 100% oxygen, which will be followed by administration of either fentanyl 1 µg/kg (made up to 10 ml saline) or 10 ml saline (prepared by a person not involved in the study). Induction of anesthesia will be performed 2-3 minutes after administration of the study drug with propofol 2.0 - 2.5 mg/kg after lidocaine 2% 20-30 mg. After loss of eyelash reflex an appropriate size LMA will be placed. If the patients become apneic, manual ventilation will be performed with oxygen/nitrous oxide and desflurane, 3% dialed concentration initially and then titrated to maintain the BIS value of 50-60.
Anesthesia will be maintained with desflurane titrated to achieve a BIS value of 50-60, along with 50% nitrous oxide and oxygen. Once spontaneous breathing resumes, fentanyl 25-50 µg will be administered to achieve a respiratory rate of 10-15 breaths/minute. Additional propofol/fentanyl will be administered, if deemed necessary by the attending anesthesiologist. All patients will receive dexamethasone 4 mg, IV after induction of anesthesia and ondansetron 4 mg 20-30 minutes prior to the end of surgery. Desflurane will be discontinued after closure of the surgical wound.
A blinded observer will record patient demographics (age, weight, height) and history of smoking from preoperative evaluation. Data collected during the intraoperative period will include need for manual ventilation and duration of manual ventilation, duration of anesthesia, total doses of propofol and fentanyl, and time from discontinuation of desflurane until patient first follows verbal command as well as heart rate (HR), mean arterial blood pressure (MAP), end-tidal carbon dioxide, oxygen saturation, and end-tidal gas concentration will be recorded every 15 minutes.
Data collected in the postoperative period will include verbal rating score (0 to 10) will be used to assess pain, nausea, and vomiting in the recovery room every 15 minutes for one hour as well as the need for rescue medications will also be recorded.
Patients will also be contacted approximately 24 hours after surgery to evaluate their post operative course including occurrence of any adverse events. The patient will remain in the study for approximately 24 hours.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center at Dallas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-64 years of age
- Subjects scheduled for elective superficial and peripheral surgery of less than 2 h duration (e.g., hernia surgery, breast surgery, upper or lower limb surgery, superficial abdominal/chest wall surgery [i.e., lipoma], minor gynecological procedures [i.e., hysteroscopy])
Exclusion Criteria:
- obesity (body mass index >30)
- pregnancy
- history of gastroesophageal reflux, hiatal hernia, significant cardiovascular, pulmonary (e.g., reactive airway disease), hepatic, renal, neurologic, metabolic, and endocrine disease
- history of alcohol and drug abuse
- requiring tracheal intubation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: FENTANYL
|
FENTANYL PRETREATMENT DURING INDUCTION OF ANESTHESIA
|
Placebo Comparator: SALINE
|
FENTANYL PRETREATMENT DURING INDUCTION OF ANESTHESIA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Movement
Time Frame: Induction of Anesthesia
|
The data provided below include participants who moved (includes all grades of movement ie, mild, moderate and severe).
|
Induction of Anesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Apnea
Time Frame: Induction of Anesthesia
|
Apnea defined as no breathing for at least 30 s.
|
Induction of Anesthesia
|
Coughing
Time Frame: Intraoperative period
|
Data include patients who coughed irrespective of the degree of coughing.
|
Intraoperative period
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Girish P Joshi, MD, University of Texas Southwestern Medical Center, Dallas
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 092010-013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Administration Site Reaction
-
Guangzhou Women and Children's Medical CenterCompletedFailed Moderate Sedation During Procedure | Administration Related Reaction | Chloral Hydrate Adverse ReactionChina
-
Tigenix S.A.U.CompletedLocalized Adverse Reaction to Administration of DrugSpain
-
University Hospital, GrenobleNot yet recruitingSevere Anaphylactic Reaction, Self-administration, Adrenaline, Self-assessment
-
Guizhou Bailing Group Pharmaceutical Co LtdCompletedGeneral Disorders and Administration Site ConditionsChina
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloCompletedAdministration, Topical | Administration, Topical Drug | Anesthetic DrugsBrazil
-
Karabuk UniversityCompletedMentoring | Comfort | Medication AdministrationTurkey
-
Sykehuset Innlandet HFNorwegian University of Science and TechnologyCompletedPatient Safety | Medication AdministrationNorway
-
Optomeditech OyCardioMed Device Consultants, LLCCompletedA Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric PopulationInjections, Intravenous | Administration, IntravenousEstonia
-
University of EdinburghNHS LothianCompletedLiver Resection | Paracetamol AdministrationUnited Kingdom
Clinical Trials on Fentanyl
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)CompletedPeer Review, ResearchUnited States
-
Alexza Pharmaceuticals, Inc.Completed
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
University of Texas Southwestern Medical CenterCompletedPregnancyUnited States
-
Samuel Lunenfeld Research Institute, Mount Sinai...Terminated
-
Janssen Research & Development, LLCCompleted
-
University of PatrasUnknownStillborn Caesarean SectionGreece
-
Johns Hopkins UniversityCompletedIntracranial SurgeryUnited States
-
Janssen Korea, Ltd., KoreaCompletedChronic PainKorea, Republic of